Aptiv's $700 Million Memory Bill Is the Whole 2027 Story
A 30% drawdown, a flat outlook, and a portfolio review hiding in plain sight.
APTV · Earnings Call · 2026-11-03
A quarter that was never about the quarter
Aptiv's Q3 revenue of $3.2B and 2% adjusted growth look almost boring. The stock is down 30% in 90 days and 77% from its 2021 peak. Price-to-revenue sits at 0.7x. The call was a 2027 reset, not a Q3 victory lap. After spinning off the Electrical Distribution Systems business into Versigent, the reported numbers are optically distorted — total revenue was down 37% year over year in the latest 10-Q — so management leaned on pro forma comparisons and asked investors to look through the separation noise. The market, judging by the tape, is not yet convinced.
Memory is the new copper
Kevin Clark opened the 2027 discussion with a blunt input-cost warning: “The industry is experiencing significant input cost inflation. For memory chips, the favorable pricing we secured for our customers in 2026 will not repeat in 2027.” — Kevin Clark, Chairman and Chief Executive Officer · 2026-11-03 Varun Laroyia then put a number on it:
Currently, we are estimating approximately $700 million in inflation related to semiconductor prices primarily memory
That is the headline. It is a pass-through, not a profit pool: neutral to EBITDA but dilutive to margin because there is little margin on the higher prices being recovered. The company locked in 2026 at low-double-digit increases on roughly $175 million of memory purchases, as Kevin reminded analysts in February: “memory, the purchase value is roughly $175 million as we sit here in 2026” — Kevin Clark, Chairman and Chief Executive Officer · 2026-02-02. Now the bill is roughly four times that. This is a memory chips problem that is also a global memory pricing problem — the same tightness showing up in the market's memory cost and memory pricing themes. Aptiv's supply chain gives it visibility and buffer stock, but not immunity. Supply constraints are now both a revenue variable and a margin variable.
The conservatism is the message
Management went out of its way to say the 2027 outlook is not a normal guide. Kevin: “we just overlaid an incremental level of conservatism above and beyond the range” — Kevin Clark, Chairman and Chief Executive Officer · 2026-11-03. In August, he would not give 2027 at all: “I won't get in specifically into 2027 at this point in time.” — Kevin P. Clark, Chairman and Chief Executive Officer · 2026-08-04 Now the base case is flat global vehicle production, with a downside of down 2%, and even the base case is called optimistic. That is a tell. The company is pre-loading bad news into 2027 so that 2028 can be the recovery year. The cost inflation language is broader than memory: copper, oil, resin, tariffs, and the affordability pressure of higher MSRPs and lease rates.
What fell off the table: the German OEM problem is now quantified
The two luxury German OEMs have been a recurring theme for several quarters, but never this explicit. Kevin: “about a third of the headwind in 2027 comes from just softer schedules, principally on export platforms... the balance is a mix of legacy program” — Kevin Clark, Chairman and Chief Executive Officer · 2026-11-03. Total value: $200 million to $300 million. The German luxury OEMs headwind now runs through the end of 2027, not just a quarter or two. That is a structural customer-mix issue in Europe, not a temporary schedule wobble. It also explains why Intelligent Systems revenue in Europe was down 5% and why management is talking about 2028 as the reacceleration year.
The non-auto pivot is real, but it is not yet a hedge
Bookings are the strongest part of the story: $4 billion in Q3, $13 billion year to date, and $3.8 billion of non-auto awards more than doubled year over year. Management expects more than $3 billion of 2026 non-auto revenue, including $2 billion in aerospace and defense, telecom/datacom, and diversified industrials. Awards include a humanoid robot program in China, data center and battery energy storage interconnect, medical cable assemblies, and telecom software. Kevin was careful to temper the humanoid hype: AMRs are the more likely high-volume use case. The Chinese OEM engine is also real — China bookings grew 30%, with more than 20% tied to export programs — but it comes with margin mix risk and geopolitical exposure. This is the same non-auto pitch from October 2025: “the opportunity is very big, especially around areas like energy storage, like robotics, like drones.” — Kevin P. Clark, Chairman and Chief Executive Officer · 2025-10-30 It is bigger now, but still roughly a quarter of revenue. It cannot yet offset a $200 million to $300 million German OEM hole and a $700 million memory pass-through in the same year.
The portfolio review is the wildcard
In August, Kevin was asked about portfolio changes and said: “I don't have any specific comments I would make at this point in time.” — Kevin P. Clark, Chairman and Chief Executive Officer · 2026-08-04 On this call: “we are evaluating the composition of our business and product portfolio, and we will provide an update in the first quarter 27.” — Kevin Clark, Chairman and Chief Executive Officer · 2026-11-03 That is a shift. It could mean divestitures, a further separation, or a re-segmentation. The buyback is running in parallel: $230 million in Q3, $550 million year to date, at least $650 million by year-end, and 100% of free cash flow returned through at least 2027. But free cash flow is thin — $44 million year to date on a pro forma basis — and effective net cash is negative $4.5 billion. The buyback signals confidence in intrinsic value; the portfolio review signals the mix may change. Both can be true, but they pull on the same balance sheet.
Bottom line
Aptiv is using a cyclical trough to reset expectations, buy back stock, and prepare a portfolio change. The 2027 guide is flat because memory pass-through adds revenue but no profit, German OEM schedules roll off, and management is deliberately sandbagging. The bull case is that non-auto bookings convert into a higher-margin, less cyclical business by 2028. The bear case is that 2027 is a lost year and the market is right to price the stock at 0.7x sales. The quarter did not resolve that debate; it just moved it to the first quarter of 2027.